LEUPROLIDE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Leuprolide Acetate patents expire, and what generic alternatives are available?
Leuprolide Acetate is a drug marketed by Amneal, Eugia Pharma, Genzyme, Meitheal, Rk Pharma, Sandoz, Sun Pharm, and Invagen Pharms. and is included in eight NDAs.
The generic ingredient in LEUPROLIDE ACETATE is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Leuprolide Acetate
A generic version of LEUPROLIDE ACETATE was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEUPROLIDE ACETATE?
- What are the global sales for LEUPROLIDE ACETATE?
- What is Average Wholesale Price for LEUPROLIDE ACETATE?
Summary for LEUPROLIDE ACETATE
Recent Clinical Trials for LEUPROLIDE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| NRG Oncology | Phase 2 |
| Johns Hopkins Bloomberg School of Public Health | Phase 2 |
| Takeda | Phase 4 |
Medical Subject Heading (MeSH) Categories for LEUPROLIDE ACETATE
US Patents and Regulatory Information for LEUPROLIDE ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | LEUPROLIDE ACETATE | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 215336-001 | Oct 28, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | LEUPROLIDE ACETATE | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 078885-001 | Mar 9, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Meitheal | LEUPROLIDE ACETATE | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 075471-001 | Oct 25, 2000 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
